No LabelCJC-1295 no DAC 5mg
| Quantity | Discount | Price |
|---|---|---|
| 3–5 | 10% | $36,00 |
| 6–9 | 15% | $34,00 |
| 10–100 | 20% | $32,00 |
Specifications
- Brand: No-Label HGH, Peptides & SARMs
- Substance: CJC-1295 no DAC
- Product Form: Powder
- Dosage: 5mg
How To Use
Laboratory Reconstitution & Research Dosing Protocols
Disclaimer: The following information is for educational and laboratory reference only. This product is strictly for in-vitro and in-vivo research and is not intended for human consumption or therapeutic use.
This vial contains 5 mg (5,000 mcg) of lyophilized powder. Complex peptide hormones require careful handling to maintain structural integrity.
Reconstitution Guide
For standard research concentration, reconstitute the 5 mg vial with 2 ml of Bacteriostatic Water.
- Preparation: Slowly inject the water against the glass wall of the vial.
- Dissolution: Swirl gently until clear. Do not shake, as the peptide bonds are highly sensitive to mechanical stress.
- Measurement Reference (Using 2 ml dilution):
- 4 Units (0.04 ml) = 100 mcg
- 8 Units (0.08 ml) = 200 mcg
- 12 Units (0.12 ml) = 300 mcg
⚠️ Storage Specifications
- Unmixed (Lyophilized): Store in a cool, dry place. For long-term preservation, store at -20°C.
- Mixed (Reconstituted): Must be refrigerated (2°C to 8°C). Use within 14-21 days for maximum analytical integrity.
Experience Level Usage Guide
Beginner
Baseline Secretagogue Model
Reference dosing for initial studies investigating the modulation of basal Growth Hormone release.
- Test Subject Dosage: 100 mcg to 200 mcg per administration.
- Frequency: Administered once daily (typically before sleep or in a fasted state).
- Research Aim: Assessment of subject tolerance and pituitary hormone pulse.
Intermediate
Systemic Metabolic Optimization Model
Standard dosage for evaluating the long-term impact of sustained GH elevation on body composition.
- Test Subject Dosage: 200 mcg to 300 mcg per administration.
- Frequency: Administered twice daily, or up to 3 times daily to simulate natural pulses.
- Observation Period: 4 to 8 weeks for longitudinal data collection.
Advanced
Advanced Somatotropic Synergy Stack
Advanced protocol investigating the synergy between GHRH analogs and Ghrelin-receptor mimetics.
- The Stack: CJC-1295 No DAC (100 mcg) + Ipamorelin (100 mcg).
- Scientific Rationale: Investigates the combined impact of GHRH receptor signaling (CJC-1295 No DAC) and GHS-R1a agonism (Ipamorelin) to maximize peak Growth Hormone pulse amplitude.
- Frequency: Combined administration up to 3 times daily for intensive research data collection.
Shipping Details
Detailed Description
What Is No Label CJC-1295 No DAC 5 mg?
No Label CJC-1295 No DAC 5 mg is a modified, non-DAC (Drug Affinity Complex) analog of the growth hormone-releasing hormone (GHRH). By removing the DAC component, this engineered 29-amino acid peptide is designed for precise, short-term pulsatile release of endogenous growth hormone rather than prolonged, continuous elevation. This 5 mg lyophilized preparation is an optimal instrument for USA domestic research facilities investigating somatotropic restoration, natural pulse-frequency modulation, and tissue repair assays.
If your research goals involve exploring the limits of the somatotropic axis or the optimization of growth hormone pulsatility, you can buy Anti-aging peptides of this analytical grade through our Muscle Growth Peptides & SARMs or Anti-Aging & Longevity Peptides category.
Important: No Label CJC-1295 No DAC 5 mg is strictly for laboratory research and is not intended for human consumption or therapeutic use.
No Label CJC-1295 No DAC 5 mg: Technical Profile
| Scientific Parameter | Details for No Label CJC-1295 No DAC |
|---|---|
| Peptide Category | GHRH (Growth Hormone-Releasing Hormone) Analog |
| Vial Concentration | 5 mg Lyophilized Powder |
| Molecular Weight | 3367.9 g/mol |
| Primary Focus | Regulated / Pulsatile Growth Hormone Secretion |
Research Benefits of No Label CJC-1295 No DAC 5 mg
In controlled laboratory settings, it is valued for its specific and natural-pulse generation. Key research benefits include:
- Controlled Pulsatility: Studying how the non-DAC variant mimics the body’s natural GHRH releases to trigger well-defined, rhythmic growth hormone pulses.
- Improved Sleep Architecture: Investigating the peptide’s ability to promote deep, slow-wave sleep phases by extending GHRH signaling in the central nervous system.
- Lean Tissue Maintenance: Researching the peptide’s role in counteracting age-related muscle wasting and improving nitrogen retention.
- Signaling Synergy: Exploring how Peptidesline’s CJC-1295 No DAC interacts with secretagogues like Ipamorelin or GHRP-2 to create amplified, natural hormonal release profiles.
How Does No Label CJC-1295 No DAC 5 mg Work?
The mechanism of CJC-1295 No DAC involves binding to the specific GHRH receptor located on the anterior pituitary gland. Without the DAC (Drug Affinity Complex), the peptide has a shorter plasma clearance half-life compared to the DAC-modified version, allowing researchers to study acute, distinct pulses without maintaining prolonged somatotrophic saturation. Because Peptidesline provides vacuum-sealed, analytical-grade products, researchers can reliably track these hormonal shifts and observe their impact on cellular regeneration with high precision.
Potential Side Effects in Research Models
Researchers utilizing CJC-1295 No DAC must monitor for physiological responses associated with its administration:
- Transient Water Retention: Potential observed effects include mild fluid retention in the extremities during long-term assays.
- Localized Flushing: Potential observed warmth or redness at the injection site.
- Hypoglycemic Variance: Studies frequently note that increased growth hormone levels can transiently lower blood glucose markers.
- Lethargy Signals: Potential signs of increased tiredness due to the shift in GHRH activity and deeper sleep stages.
CJC-1295 No DAC vs. Alternative Secretagogues
| Research Peptide | Primary Mechanism | Main Research Strength |
|---|---|---|
| Sermorelin | GHRH 1-29 Analog | Shortest clearance half-life for highly acute pulsatility. |
| Ipamorelin | Ghrelin Mimetic | Induces a quick, immediate surge of growth hormone. |
| CJC-1295 with DAC | GHRH + DAC | Extended systemic presence and elevated baseline levels. |
| CJC-1295 No DAC 5 mg | Modified GHRH Analog | Pulsatile GH release with controlled biological half-life. |
Buy No Label CJC-1295 No DAC 5 mg Online
When conducting critical endocrine assays, Peptidesline is your reliable source for batch-certified compounds. Our CJC-1295 No DAC is HPLC-verified for 100% integrity.
- Express USA Delivery: Fast shipping to your research facility in 4-7 business days.
- Secure Checkout: Simple payment options via Zelle or Venmo.
- 10% Crypto Discount: Unlock a 10% discount on CJC-1295 No DAC 5 mg by paying with Bitcoin or USDT.
- Click here for Payment Options
FAQ
The No DAC variant clears the system much more quickly, allowing researchers to study distinct and pulsatile growth hormone bursts rather than a prolonged, steady-state concentration.
The 5 mg format provides the necessary yield for sustained titration studies, ensuring researchers on Peptidesline maintain batch consistency throughout the study.
Yes, GHRH analogs like CJC-1295 are heavily studied for their ability to promote slow-wave sleep stages by keeping GHRH receptors stimulated.
Yes. This peptide is non-hormonal, meaning it won't affect a woman's natural cycle or a man's testosterone. It is considered one of the safest entry-level research subjects in the peptides usa market. At Peptidesline.com, we see many users start with the 5 mg vial because it is gentle and easy to control.
In laboratory environments, the No DAC version has an observed half-life of approximately 30 minutes to 2 hours, making timing vital for data collection.
Yes, many researchers on Peptidesline combine GHRH analogs like CJC-1295 with secretagogues like Ipamorelin to replicate the body's natural pulsatile release of GH.
